Alembic Pharma Gets USFDA Approval

  Published 10 months ago

Alembic Pharmaceuticals has received final approval from the USFDA for its Amlodipine and Atorvastatin Tablets USP. This allows the company to market a generic version of the drug in the US market.

  • USFDA approved Alembic's ANDA.
  • Amlodipine & Atorvastatin tablets approved.
  • Expands Alembic's US generic portfolio.

You might like these

Ashiana Senior Living Project in Chennai

Dixon Tech Q1 Profit Surges 68%

SEBI’s Derivatives Market Growth Plan

Lupin Launches Generic Oxcarbazepine ER Tablets in the U.S.

TBO Acquires Classic Vacations

Bajaj Auto FY25: Mixed Results & Growth

India's Economic Resilience Amid Global Headwinds

News that matters the most ⚡